×

IDENTIFICATION OF ABERRANT MEASUREMENTS OF IN VIVO GLUCOSE CONCENTRATION USING TEMPERATURE

  • US 20110152658A1
  • Filed: 12/17/2010
  • Published: 06/23/2011
  • Est. Priority Date: 12/17/2009
  • Status: Abandoned Application
First Claim
Patent Images

1. A method of identifying whether an intravascular glucose measurement is aberrant, the method comprising:

  • deploying a sensor within a blood vessel, wherein the sensor comprises along a distal region thereof, a temperature-sensing element adapted to measure the temperature of the blood contacting the distal region, and a glucose-sensing chemical indicator system adapted to measure the glucose concentration in the blood contacting the distal region;

    generating at a first time, a first temperature measurement (TO;

    generating at a second time, a second temperature measurement (T2) and a glucose measurement;

    comparing T1 and T2; and

    identifying the glucose measurement as aberrant if the absolute magnitude of the difference between T1 and T2 exceeds a pre-selected threshold value.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×